Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region – Global Forecast to 2025

2020-05-19
Price :
Published : May-2020
No. of Pages : 193

“The ostomy care market projected to grow at a CAGR of 4.4% over the forecast period of 2020-2025.”

The ostomy care market is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Globally, the population of individuals aged 60 years and above is expected to increase from 962 million in 2017 to 2.1 billion by 2050 (Source: UN Population Division). The rising geriatric population is considered as one of the major factors driving the growth of the ostomy care industry, as the incidence of bladder cancer and colorectal cancer is high among geriatric individuals. Thus, the rising geriatric population, coupled withthe growing number of awareness programs to educate patients regarding the use of ostomy products,are the major factors driving the growth of this market. However, discomfort and other issues associated with the use of ostomy bags and the growing adoption of alternative treatments are the key factors limiting the growth of this market.

“The ostomy accessories segment is expected to be the fastest-growing segment during the forecast period.”

The ostomy accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about the care of peristomal skin.

“The two-piece bags segment expected to be the largest segment in 2019.”

By ostomy bag type, the ostomy care market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the largest share of the market in terms of volume in 2019.The major share of the segment is attributed to the advantages of these bags over one-piece bags and a rising number of ileostomy procedures.

“Asia Pacific expected to register the highest growth rate in the ostomy care market.”

The ostomy care industry is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Awareness initiatives by public and private organizations, a large patient population base for target diseases, and the rising geriatric population are the key factors driving the market growth. In addition, several market players are focusing on strengthening their distribution networks in APAC markets to capitalize on the growth opportunities in this region, are expected to boost the growth of this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
  • By Designation: C-level–47%, Director-level–33%, and Others–20%
  • By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

The major players in the ostomy care market include Coloplast A/S (Denmark), Hollister Incorporated (US), ConvaTec Group plc (UK), B. Braun (Germany), ALCARE Co., Ltd. (Japan), Nu-Hope (US), Marlen Manufacturing & Development Company (US), Welland Medical Limited (UK), Baohe Ostomy Care (China), Flexicare Medical Limited (UK), Cymed (US), Schena Ostomy Technologies, Inc. (US), Perma-Type Company Inc. (US), 3M (US), Smith & Nephew (US), and Salts Healthcare (UK), among others.

Research Coverage

This report studies the stoma/ostomy care market based on the product, end user,and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions(and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ostomy care market
  • Product Development/Innovation: Detailed insights on research and development activities and new product launches in the ostomy care industry
  • Market Development: Comprehensive information about lucrative emerging markets, by product, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments in the ostomy care market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the ostomy care market
Filed in: Medical Device
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User – Global Forecast to 2025

“Cardiac monitoring & cardiac rhythm management devices market is projected to grow at CAGR of 4.0% from 2020 to 2025” The global cardiac monitoring & cardiac rhythm management devices market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025. The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Also, measures to reduce infections caused due to CIEDs to offer an opportunity for the growth of the market during the forecast period. “......
$4950

Ophthalmic Equipment Market by Product (OCT, Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Excimer Laser, OVDs, Phacoemulsification) End User (Hospital, Consumer) – Global Forecast to 2025

“The ophthalmic equipment market is projected to grow at a CAGR of 3.7% during the forecast period.” The global ophthalmic equipment market size is projected to reach USD 63.3 billion by 2025 from USD 52.8 billion in 2020, at a CAGR of 3.7% during the forecast period. The market for ophthalmic equipment is driven primarily by the factors such as the rising geriatric population and prevalence of eye diseases, technological advancements in ophthalmic devices, government initiatives to control visual impairment, and the rising adoption of contact lenses and spectacles. However, the high cost of ophthalmology devices, cuts in the reimbursement for ophthalmic surgical procedures, and the increased adoption of refurbished devices will hinder the overall adoption of ophthalmic equipment an......
$7150

Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) – Global Forecast to 2025

“The global prefilled syringes  market is projected to grow at a CAGR of 9.0% during the forecast period” The global prefilled syringes market size is projected to reach USD 8.6 billion by 2025 from USD 5.6 billion in 2020, at a CAGR of 9.0%. The growth in the prefilled syringes market is majorly driven by the rising demand for prefilled syringes is attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market, is supporting the g......
$

Sports Medicine Market by Product (Body Reconstruction, Body Support & Recovery), Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), End User (Hospitals, Physiotherapy Centers & Clinics) – Analysis & Global Forecast to 2025

“The sports medicine market is projected to grow at a CAGR of 5.7% during the forecast period.” The global sports medicine market is projected to reach USD 7.2 billion by 2025 from USD 5.5 billion in 2020 at a CAGR of 5.7%. Growth in the sports medicine market can be attributed to factors such as the increasing incidence of sports injuries, continuous influx of new products and treatment modalities, developments in the field of regenerative medicine and rising demand for minimally invasive surgeries. However, the high cost of implants and other devices may restrain the market to a certain extent. “The Body Support & Recovery Products segment is expected to grow at the highest rate during the forecast period.” On the basis of product, the global sports medicine market h......
$4950

Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region – Forecasts to 2025

“Veterinary care market is predicted to foresee exceptional growth in the coming years.” The veterinary care market has experienced considerable growth since the past few years. Market growth can be associated with the introduction of highly efficient veterinary diagnostic tools that enables early disease diagnosis.  The disease diagnosis rate in companion, as well as livestock, has drastically explicitly increased in South East Asian countries. Moreover, veterinary market growth can be traced via the animal health market that is also growing significantly. For instance, Asia Pacific animal health market size is projected to reach ~ USD 23 billion by 2025 from around USD 17 billion in 2018, at a CAGR of 5.2% during the forecast period. The market growth is attributed to the rising ......
$5650

Cardiovascular Imaging Equipment – Medical Devices Pipeline Assessment, 2020

Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiovascular Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Cardiovascular Imaging Equipments are the imaging devices that capture the images of heart to diagnose the condition of heart. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Cardiovascular Imaging Equipment under deve......
$2500

Coronary Guidewires – Medical Devices Pipeline Assessment, 2020

Coronary Guidewires - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Coronary Guidewires - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Coronary Guidewires under development - The report reviews details of major pipeline produ......
$2500

Clinical Decision Support Systems – Medical Devices Pipeline Assessment, 2020

Clinical Decision Support Systems - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Clinical Decision Support Systems - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Clinical Decision Support Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Clinical Decision Support Systems (CDSS) are software tools which assist healthcare professionals with decision-making by consolidating a medical knowledge base with patient information to produce case-specific advice. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the ......
$4000

Idiopathic Pulmonary Fibrosis – Epidemiology Forecast to 2029

Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2029 Summary Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease and is a serious chronic condition that affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition occurs when the lung tissue becomes thick and stiff for unknown reasons. Over time, breathing becomes difficult due to fibrosis caused by permanent scarring in the lungs (NHLBI, 2019). IPF is associated with a poor prognosis, with a median survival of three to five years (Raghu et al., 2011). There is currently no cure for IPF. However, certain medicines may slow the progression of IPF, which may extend the lifespan and improve the quality of life for people who have the disease (NHLBI, 2019). GlobalData epidemiologists ......
$3995

Pulmonary Arterial Hypertension – Epidemiology Forecast to 2029

Pulmonary Arterial Hypertension - Epidemiology Forecast to 2029 Summary Pulmonary arterial hypertension (PAH) is a rare, progressive disorder characterized by vascular proliferation and remodeling of the small pulmonary arteries (Humbert et al., 2004; Humbert et al., 2010; Simonneau et al., 2004). In PAH, blood vessels in the lungs are narrowed, blocked, or destroyed. The damage slows blood flow through the lungs (Mayo Clinic, 2020). This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure (Humbert et al., 2004, 2010; Simonneau et al., 2004). GlobalData epidemiologists utilized national databases, registries, and robust peer-reviewed journal articles to build the diagnosed incident and diagnosed prevalent cases of PAH......
$3995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy